[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a …
Background There are few primary care studies of the COVID-19 pandemic. We aimed to
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013
G Dabrera, G Amirthalingam, N Andrews… - Clinical Infectious …, 2015 - academic.oup.com
Background. Infants with pertussis infection are at risk of severe clinical illness and death.
Several countries, including the United Kingdom, have introduced maternal pertussis …
Several countries, including the United Kingdom, have introduced maternal pertussis …
[HTML][HTML] Emergence of a novel coronavirus (COVID-19): protocol for extending surveillance used by the Royal College of General Practitioners Research and …
…, R Byford, A Charlett, G Dabrera… - JMIR public health …, 2020 - publichealth.jmir.org
JMIR Public Health and Surveillance - Emergence of a Novel Coronavirus (COVID-19):
Protocol for Extending Surveillance Used by the Royal College of General Practitioners …
Protocol for Extending Surveillance Used by the Royal College of General Practitioners …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a …
Background The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine
escape and high transmissibility, with early studies indicating lower severity of infection …
escape and high transmissibility, with early studies indicating lower severity of infection …
[HTML][HTML] Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
…, L Geidelberg, WR Hinsley, DJ Laydon, G Dabrera… - Nature, 2021 - nature.com
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public
Health England 1 , was first identified in the UK in late summer to early autumn 2020 2 . …
Health England 1 , was first identified in the UK in late summer to early autumn 2020 2 . …
[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines
…, S Thelwall, N Groves, G Dabrera… - … England Journal of …, 2022 - Mass Medical Soc
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …
…, D De Angelis, AM Presanis, G Dabrera… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
[HTML][HTML] Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant
…, S Thelwall, G Dabrera… - … England Journal of …, 2022 - Mass Medical Soc
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …